TY - JOUR T1 - A comparison of performance metrics for cloth face masks as source control devices for simulated cough and exhalation aerosols JF - medRxiv DO - 10.1101/2021.02.16.21251850 SP - 2021.02.16.21251850 AU - William G. Lindsley AU - Francoise M. Blachere AU - Donald H. Beezhold AU - Brandon F. Law AU - Raymond C. Derk AU - Justin M. Hettick AU - Karen Woodfork AU - William T. Goldsmith AU - James R. Harris AU - Matthew G. Duling AU - Brenda Boutin AU - Timothy Nurkiewicz AU - John D. Noti Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/19/2021.02.16.21251850.abstract N2 - Universal mask wearing is recommended by the Centers for Disease Control and Prevention to help control the spread of COVID-19. Masks reduce the expulsion of respiratory aerosols (called source control) and offer some protection to the wearer. However, masks vary greatly in their designs and construction materials, and it is not clear which are most effective. Our study tested 15 reusable cloth masks (which included face masks, neck gaiters, and bandanas), two medical masks, and two N95 filtering facepiece respirators as source control devices for aerosols ≤ 7 µm produced during simulated coughing and exhalation. These measurements were compared with the mask filtration efficiencies, airflow resistances, and fit factors. The source control collection efficiencies for the cloth masks ranged from 17% to 71% for coughing and 35% to 66% for exhalation. The filtration efficiencies of the cloth masks ranged from 1.4% to 98%, while the fit factors were 1.3 to 7.4 on an elastomeric manikin headform and 1.0 to 4.0 on human test subjects. The correlation coefficients between the source control efficacies and the other performance metrics ranged from 0.31 to 0.66 and were significant in all but one case. However, none of the alternative metrics were strong predictors of the source control performance of cloth masks. Our results suggest that a better understanding of the relationships between source control performance and metrics like filtration efficiency, airflow resistance, and fit factor are needed to develop simple methods to estimate the effectiveness of masks as source control devices for respiratory aerosols.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study was not a clinical trialFunding StatementThis work was supported by the CDC and by the National Institutes of Health under Grants NIH R01 ES015022 (TRN) and NIH U54 GM104942 to the West Virginia University researchers.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Because only fit factors were measured on human subjects and no identifiable private information was collected, the West Virginia University Office of Human Research Protections determined that Institutional Review Board approval was not required. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy (see e.g., 45 C.F.R. part 46; 21 C.F.R. part 56; 42 U.S.C. 241(d), 5 U.S.C. 552a, 44 U.S.C. 3501 et seq.).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe experimental data is provided in the manuscript tables and the supplemental information. More detailed data is available upon request. ER -